Assessment of Patient Radiation Exposure and Development of Diagnostic Reference Levels(DRLs) Standards for Endoscopic Retrograde Cholangiopancreatography (ERCP).
ERCP is a fluoroscopy procedures are associated with significant radiation exposure to patients. Radiation exposure is associated with adverse effects both short term and long term which might negatively impact the quality of life of the patient. The effects of radiation maybe deterministic or stochastic the effects may range from mild such as skin irritation to long term effects such as cancer. Hence there is a need to limit the dosage of radiation exposed to the patient. Therefore, there is a need to establish standard reference levels. Radiation is measured in Dose Area Product (DAP), Effective dose (ED), Reference air Kerma (Ka,r). The radiation exposure is measured for the patients undergoing ERCP from January 2023 to Dec 2025 will be collected. DRLs will be calculated for these metrics. DRL is 3rd quartile of the measured values. The dosage of radiation which the patient receives depends on several factors such as patients BMI, position, complexity of the procedure and several other factors. As a secondary objective several factors affecting the radiation exposure is also noted.
研究概览
地位
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Settipally Vinay kumar, M.D
- 电话号码:91 9848883993
- 邮箱:settipallyvsk@gmail.com
研究联系人备份
- 姓名:Vikram Bhatia, D.M
- 电话号码:91 9818014864
- 邮箱:vikrambhatiadr@gmail.com
参与标准
资格标准
适合学习的年龄
- 孩子
- 成人
- 年长者
接受健康志愿者
有资格学习的性别
取样方法
研究人群
All consecutive in-patients and out-patients undergoing ERCP .
描述
Inclusion Criteria: • Patients Undergoing ERCP -
Exclusion Criteria: Patients with missing dosimetry data
-
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:RETROSPECTIVE
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Estimate the distribution of total radiation dose (median, IQR, 75th percentile) reflected by DAP (Gy·cm²) for ERCP and propose local DRLs.
大体时间:Day 0
|
Day 0
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
- Estimation of Diagnostic reference (DRLs) -(median, IQR, 75th percentile)for ERCP procedures for Ka,r (in mGy) , FT (in min),ED(in mSv).
大体时间:Day 0
|
Day 0
|
|
- Patient's fluoroscopy time (in min), reference air-kerma (in mGy), and number of acquisitions(n) will be measured
大体时间:Day 0
|
Day 0
|
|
- Correlation of DAP and Ka,r with ASGE complexity grade, HOUSE grading, Stanford fluoroscopy complexity scores will be done using Spearman rank correlation coeffecient
大体时间:Day 0
|
Day 0
|
|
- Track proportion of cases exceeding candidate DRLs or published reference values to guide procedure optimization.
大体时间:Day 0
|
Day 0
|
|
Multivariate regression will be used for correlation of procedure indication, BMI(kg/m²), prior sphincterotomy(yes/no), trainee involvement (yes/no), collimation(yes/no), and image acquisitions with DAP(Gy·cm²) and Ka,r (in mGy)
大体时间:Day 0
|
Day 0
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- ILBS-ERCP-01
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.